Merck Articles
Stock Commentary - Europe - week to Oct 6, 2008
13 October 2008
Merck & Co stops taranabant at Ph III
13 October 2008
World neglected tropical disease round-up
13 October 2008
Newron gets 5M-euro govt contract
13 October 2008
Japan stock market week to Oct 6, 2008
13 October 2008
PML doctor warnings issued for Raptiva
13 October 2008
US and UK Prix Galien awards 2008, winners announced
6 October 2008
Merck & Co joins Lilly in transparency move
6 October 2008
Stock Commentary - Europe - week to Sept 29, 2008
6 October 2008
Is ImClone's mystry bidder Eli Lilly?
6 October 2008
Idera reports first data from carcinoma trial
6 October 2008
More indications for Merck & Co's Gardasil
6 October 2008
Thailand's new Health Minister will keep CLs
6 October 2008
NHS physicians "under pressure" to switch Rxs
6 October 2008
Nitec secures 24M SwFr funding
6 October 2008
Merck & Co drug gets first nod under PIP
6 October 2008
List of new CHMP drug recommendations
6 October 2008
UPDATE: B-MS goes to ImClone shareholders with slightly higher bid, which Icahn rejects
29 September 2008
Merck & Co in-licenses novel osteoanabolic drug from Japan Tabacco
29 September 2008
Merck KGaA Rebif trial meets endpoint
29 September 2008
Thailand's HIV/AIDS drug resistance problem
29 September 2008
Brazil OKs copy of Merck's Stocrin
29 September 2008
2-year data for Merck & Co's odanacatib
29 September 2008
Cladribine enters trial in patients at risk of MS
29 September 2008
Benefits of Erbitux in WT-KRAS mCRC tumors highlighted at ESMO
22 September 2008
Retail drug sales in year to July 2008
22 September 2008
Two new indications for Merck & Co's HPV vacc
22 September 2008
Erbitux increases overall survival in SCCHN
15 September 2008
Merck & Co's Vioxx lawsuit reinstated, firm may appeal decision
15 September 2008
GSK appoints Ellen Strahlman as CMO
15 September 2008
B-MS will not raise bid for ImClone
15 September 2008
Merck Serono's Glucophage sachet gets nod from CHMP
15 September 2008
Byetta: better post-meal glucose reduction than Januvia
15 September 2008
European cardiologists point to gap in cardiovascular disease management
15 September 2008
Two-year efficacy for Januvia plus metformin
15 September 2008
Ablynx in 335M-euro deal with Merck KGaA
15 September 2008
Early use of Merck & Co's Aggrastat benefits STEMI patients
8 September 2008
ZymoGenetics restructures atacicept partnership with Merck Serono
8 September 2008
Divided opinion on Vytorin despite
8 September 2008
ImClone offers more data from Erbitux trial
8 September 2008
Study finds no suicide link with Merck & Co's Singulair
8 September 2008
Skyepharma further reduces loss in first half
8 September 2008
New Ph II SA trial for Intercell/Merck & Co
1 September 2008
FDA investigates Vytorin link to cancer risk in SEAS study
1 September 2008
NEJM article questions Gardasil's adult efficacy
1 September 2008
ATLIS survey shows concern over ART side effects
1 September 2008
PDCO gives word on PIPs from latest meeting
1 September 2008
AstraZeneca's Crestor to be co-promoted with Abbott Labs in USA
1 September 2008
Mylan swings to a 2nd-qtr 2008 loss on Merck
18 August 2008
UK's NHS presses for more compensation
18 August 2008
Merck & Co's Cancidas gets expanded US label
18 August 2008
Drug majors protest FASB legal cost disclosure plan
18 August 2008
Retail drug sales in year to June 2008
18 August 2008
Rx drug prices "double" US political impact
18 August 2008
Merck & Co re-evaluating DME study design
18 August 2008
Isentress works well in untreated HIV patients
18 August 2008
Intellego expands expertise with Zenosis acquisition
11 August 2008
Gilead leads in selling Atripla in new countries
11 August 2008
Stock Commentary - New York week to July 28, 2008
4 August 2008
Merck Serono to grow Japanese business
4 August 2008
Retail drug sales in year to May 2008
4 August 2008
NicOx' 1st-half net loss widens to 33.1M euros
4 August 2008
Greater LDL drop with "naturopathic" therapy
4 August 2008
Stock Commentary - New York week to July 21, 2008
28 July 2008
Merck & Co gains EU appro for Janumet
28 July 2008
Merck & Co income still up despite low sales
28 July 2008
Retail drug sales in year to April 2008
28 July 2008
France finally approves Merck & Co
28 July 2008
Merck KGaA 's Erbitux gets broader use in mCRC
28 July 2008
Praziquantel may help slow HIV/AIDS transmission
28 July 2008
Ranbaxy wins another UK court battle with SFO
28 July 2008
India govt "considering" bulk drug deals
28 July 2008
Abbott's 2nd qtr results beat expectations
28 July 2008
Merck & Co to start $4.85B Vioxx payout
28 July 2008
MSD gains European approval for Tredaptive
21 July 2008
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
